rac-Vazegepant-13Cd3

SL-11848

rac-Vazegepant-13Cd3, >98%

Synonyms : rac-Zavegepant-13Cd3; rac- BHV-3500-13Cd3

IUPAC Name : N-(3-(7-Methyl-1H-indazol-5-yl)-1-(4-(1-(methyl-13C-d3)piperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : rac-Vazegepant-13Cd3 is a racemic, double-labelled version of Vazegepant. This can be used as an analytical labelled reference standard. Vazegepant is an orally active CGRP receptor antagonist used in migraine research and can also be given intranasally. CGRP plays a key role in migraine pathophysiology.

References : Moreno-Ajona D. et al.: Curr Opin Neurol., 33(3), 309-315, 2020; Gene M. D. et al.: Med Chem., 63(13), 6600-6623, 2020; Capi M. et al.: Springer International Publishing, 67-72, 2022; Jessica Barreto R. D. S. et al.: Eur. J. Pharmacol., 922, 174902, 2022.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.